Holme PA - Search Results

1

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome.

Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE. Barratt-Due A, et al. Among authors: holme pa. Rheumatology (Oxford). 2016 Jul;55(7):1337-9. doi: 10.1093/rheumatology/kew040. Epub 2016 Apr 22. Rheumatology (Oxford). 2016. PMID: 27105662 Free PMC article. No abstract available.

2

Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries.

Holme PA, Tjønnfjord GE. Holme PA, et al. Haemophilia. 2019 Jan;25(1):54-59. doi: 10.1111/hae.13625. Epub 2018 Nov 5. Haemophilia. 2019. PMID: 30394617

3

Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.

Tran HT, Tjønnfjord GE, Holme PA. Tran HT, et al. Among authors: holme pa. Haemophilia. 2014 Jan;20(1):141-6. doi: 10.1111/hae.12256. Epub 2013 Aug 28. Haemophilia. 2014. PMID: 23992369

4

Continuous infusion of coagulation factor concentrates during intensive treatment.

Holme PA, Tjønnfjord GE, Batorova A. Holme PA, et al. Haemophilia. 2018 Jan;24(1):24-32. doi: 10.1111/hae.13331. Epub 2017 Sep 5. Haemophilia. 2018. PMID: 28873263 Review.

5

Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors.

Tjønnfjord GE, Holme PA. Tjønnfjord GE, et al. Among authors: holme pa. Vasc Health Risk Manag. 2007;3(4):527-31. Vasc Health Risk Manag. 2007. PMID: 17969383 Free PMC article. Review.

6

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.

Schultz NH, Sørvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, Wiedmann M, Aamodt AH, Skattør TH, Tjønnfjord GE, Holme PA. Schultz NH, et al. Among authors: holme pa. N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9. N Engl J Med. 2021. PMID: 33835768 Free PMC article.

7

Haemophilic arthropathy: long-term outcomes in 107 primary total knee arthroplasties.

Westberg M, Paus AC, Holme PA, Tjønnfjord GE. Westberg M, et al. Among authors: holme pa. Knee. 2014 Jan;21(1):147-50. doi: 10.1016/j.knee.2013.09.010. Epub 2013 Oct 7. Knee. 2014. PMID: 24156923

8

Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.

Holme PA, Brosstad F, Tjønnfjord GE. Holme PA, et al. Haemophilia. 2005 Sep;11(5):510-5. doi: 10.1111/j.1365-2516.2005.01136.x. Haemophilia. 2005. PMID: 16128896

9

A dominant STIM1 mutation causes Stormorken syndrome.

Misceo D, Holmgren A, Louch WE, Holme PA, Mizobuchi M, Morales RJ, De Paula AM, Stray-Pedersen A, Lyle R, Dalhus B, Christensen G, Stormorken H, Tjønnfjord GE, Frengen E. Misceo D, et al. Among authors: holme pa. Hum Mutat. 2014 May;35(5):556-64. doi: 10.1002/humu.22544. Epub 2014 Apr 9. Hum Mutat. 2014. PMID: 24619930

10

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial.

Ghanima W, Khelif A, Waage A, Michel M, Tjønnfjord GE, Romdhan NB, Kahrs J, Darne B, Holme PA; RITP study group. Ghanima W, et al. Among authors: holme pa. Lancet. 2015 Apr 25;385(9978):1653-61. doi: 10.1016/S0140-6736(14)61495-1. Epub 2015 Feb 5. Lancet. 2015. PMID: 25662413 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page